Repligen Corp at JPMorgan Healthcare Conference Transcript
All right. Great. Thank you, everybody, for joining us today. My name is Casey Woodring from the life science tools and diagnostics team here at JPMorgan. Pleased to be joined by the management team of Repligen. We'll do the corporate presentation first and then leave time for Q&A.
So with that, Olivier, over to you.
Thank you so much, Casey. Thanks for coming, and looking forward to telling you a bit more about Repligen. The usual Safe Harbor statement.
So for those of you who are not completely familiar with the company, we are headquartered in Waltham, Massachusetts. We are really a pure bioprocessing play, about 2,000 employees in total. And for the vast majority of our portfolio, we've got dual manufacturing in US and in Europe. And finally, at the midpoint of our guidance in 2025, we were at USD733 million in sales.
What's our vision? We want to be the global innovation, and you will hear me mentioning
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
